Key Insights

Highlights

Treatment Research

1 treatments under study, led by Newcastle Virus

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00348842Phase 2Withdrawn

Newcastle Disease Virus (NDV) for Cancer Patients Resistant to Conventional Anti-cancer Modalities

Showing all 1 trials

Research Network

Common Treatments

  • Newcastle Virus1

Active Sponsors

  • Hadassah Medical Organization1

Top Investigators

Related Conditions

  • Metastatic Cancer1

Activity Timeline